AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 29984691
Drug: Personalised OHA
RxNorm normalized name: 4-OHAD
DrugBank: Formestane (DB08905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalised OHA with 6-monthly PI
Trial: 26679763
Drug: n-3 PUFA
RxNorm normalized name: 22:6(n-3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: n-3 PUFA (2.2 g/day)
Trial: 23077137
Drug: Sitagliptin 100-mg
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 100-mg administered on Day 5 of a 7 day course of simvastatin 80-mg once daily
Trial: 23077137
Drug: Sitagliptin 100-mg
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitagliptin 100-mg alone
Trial: 20889472
Drug: Participants who
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Participants who reported binge eating prior to or during treatment
Trial: 12536245
Drug: Indirect radionuclide
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indirect radionuclide cystography (IRNC) using technetium‐99m diethylene triamine penta‐acetate (DTPA) with a dosage of 37 MBq/10 kg body weight.
Trial: 8896777
Drug: Dim red
RxNorm normalized name: acid red 35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dim red light (50 lx) for 2 hours daily for 1 week
Trial: 6630409
Drug: Prior receptor
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior receptor blockade with naloxone and atropine
Trial: 26660041
Drug: heparin 1000
RxNorm normalized name: HEPARIN 10000UNIT/ML CARPUJECT 0.5ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: heparin 1000 units/mL
Trial: 20837894
Drug: Non-ICD medical
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-ICD medical therapy
Trial: 11856076
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg omeprazole once daily
Trial: 10434832
Drug: ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 4 mg i.v.
Trial: 23622912
Drug: Mild CKD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mild CKD (60-89 mL/min)
Trial: 23622912
Drug: Moderate CKD
RxNorm normalized name: CKD-504
DrugBank: CKD-504 (DB18235)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate CKD (30-59 mL/min)
Trial: 23622912
Drug: Severe CKD
RxNorm normalized name: acetaminophen / diphenhydramine hydrochloride Oral Tablet [Tylenol Severe Allergy]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Severe CKD (<30 mL/min)
Trial: 19339808
Drug: Pollen group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pollen group (received grass pollen, grass and olive pollen, or hazel, alder and birch pollen according to a 3-week titration cluster)
Trial: 19339808
Drug: HDM group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HDM group (received HDM extract according to a 2-week titration cluster)
Trial: 15053895
Drug: DPT-1 parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DPT-1 parenteral trials (insulin administration)
Trial: 8385230
Drug: Minimum methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimum methadone services (MMS) - methadone alone (a minimum of 60 mg/d) with no other services
Trial: 3544605
Drug: Heparin-dihydroergotamine twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-dihydroergotamine twice a day
Trial: 25385173
Drug: telmisartan and
RxNorm normalized name: telmisartan and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: telmisartan and atorvastatin (ARB)
Trial: 950374
Drug: Insulin (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (0.1 IU/kg BW) administered at various times (0400 h, 0800 h, 1200 h, 1600 h, 2000 h, 2400 h)
Trial: 26121460
Drug: Basal-bolus regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal-bolus regimen with glargine once daily and glulisine before meals (n = 66)
Trial: 26121460
Drug: NPH twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NPH twice daily and regular insulin before meals (n = 68)
Trial: 16191910
Drug: Oral health
RxNorm normalized name: CETYLPYRIDINIUM CHLORIDE 0.07 g in 100 mL ORAL RINSE [Assured Oral Health Fresh Mint]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral health program including parent education, toothbrushing instruction, and fluoride tablets (0.25 mg/day)
Trial: 10655292
Drug: Medi-Jector administration
RxNorm normalized name: Medi-Lyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medi-Jector administration of ganirelix (2 mg s.c. once daily for 7 days)
Trial: 10655292
Drug: Conventional needle
RxNorm normalized name: NEEDLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional needle injection of ganirelix (2 mg s.c. once daily for 7 days)
Trial: 27742577
Drug: Controlled-release oral
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release oral morphine
Trial: 18775429
Drug: Anti-Hp therapy
RxNorm normalized name: Anti-CD5 CAR T-cell therapy
DrugBank: Anti-CD5 CAR T-cell therapy (DB17279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-Hp therapy plus iron (amoxicillin, clarithromycin, and omeprazole + 90-day oral ferrous sulfate)
Trial: 18775429
Drug: Anti-Hp therapy
RxNorm normalized name: Anti-CD5 CAR T-cell therapy
DrugBank: Anti-CD5 CAR T-cell therapy (DB17279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-Hp therapy plus iron
Trial: 18775429
Drug: Anti-Hp therapy
RxNorm normalized name: Anti-CD5 CAR T-cell therapy
DrugBank: Anti-CD5 CAR T-cell therapy (DB17279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-Hp therapy alone
Trial: 8911832
Drug: NaHCO3 (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaHCO3 (0.3 g.kg‐1 body mass)
Trial: 8388090
Drug: IV cyclophosphamide/ACTH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV cyclophosphamide/ACTH with outpatient IV cyclophosphamide boosters (700 mg/m2 every other month for 2 years)
Trial: 3725002
Drug: Ethanol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (0.5 ml/kg) alone
Trial: 6487494
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + Ethanol (0.5 ml/kg)
Trial: 3725002
Drug: Amitriptyline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amitriptyline (50 mg) alone
Trial: 25518506
Drug: Dinitrosyl iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dinitrosyl iron complex (1.5 or 3 mg/kg)
Trial: 22507264
Drug: Yoga therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga therapy (suryanamaskara, asanas, pranayama, and meditation) for 1 hour per day for 12 weeks
Trial: 18544464
Drug: Disease management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease management program for smoking cessation combining pharmacotherapy, telephone counseling, and physician feedback, repeated intervention over two years.
Trial: 10397414
Drug: Duration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duration of illness, neuroleptic medication, and negative symptoms
Trial: 30531478
Drug: Cebranopadol 200
RxNorm normalized name: Cebranopadol
DrugBank: Cebranopadol (DB12830)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cebranopadol 200 μg
Trial: 30531478
Drug: Cebranopadol 400
RxNorm normalized name: Cebranopadol
DrugBank: Cebranopadol (DB12830)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cebranopadol 400 μg
Trial: 30531478
Drug: Cebranopadol 800
RxNorm normalized name: Cebranopadol
DrugBank: Cebranopadol (DB12830)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cebranopadol 800 μg
Trial: 2457074
Drug: Hydromorphone 8
RxNorm normalized name: HYDROmorphone 8 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone 8 mg
Trial: 30531478
Drug: Hydromorphone 16
RxNorm normalized name: HYDROmorphone 16 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone 16 mg
Trial: 24759796
Drug: Prasugrel (20/3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel (20/3.75 mg)
Trial: 25342212
Drug: Clopidogrel (300/75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300/75 mg)
Trial: 15356662
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (average weight loss of 28 kg)
Trial: 15356662
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (weight stable)
Trial: 8302340
Drug: Riluzole (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Riluzole (100 mg per day)
Trial: 2735022
Drug: Kinetic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kinetic treatment table (KTT)
Trial: 1093638
Drug: Ampicillin (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin (two oral doses of 1 g. 5 hours apart)
Trial: 30987813
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D3 (500 IU/d)
Trial: 26054203
Drug: Simple acupuncture
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple acupuncture therapy
Trial: 18695308
Drug: Dalteparin (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (low molecular-weight heparin)
Trial: 2429844
Drug: Propafenone 300
RxNorm normalized name: propafenone 300 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 300 mg single dose
Trial: 2429844
Drug: Propafenone 150
RxNorm normalized name: propafenone 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 150 mg t.i.d. multiple doses
Trial: 2429844
Drug: Propafenone 150
RxNorm normalized name: propafenone 150 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propafenone 150 mg and 300 mg single doses
Trial: 27147591
Drug: CBT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBT plus modafinil (400 mg/day)
Trial: 25011693
Drug: Irbesartan 300mg
RxNorm normalized name: IRBESARTAN 300MG TAB
DrugBank: Irbesartan (DB01029)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Irbesartan 300mg daily
Trial: 8695711
Drug: TPN with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TPN with a catheter through which antibiotic medication is administered in 'Y' (Group II)
Trial: 8695711
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of infection and number of days of treatment with TPN
Trial: 1505148
Drug: N-acetylcysteine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (100 mg/kg)
Trial: 6702463
Drug: Activated charcoal
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Activated charcoal (50 g) after quinidine sulfate (200 mg)
Trial: 9862245
Drug: Interferon alpha‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alpha‐2b (IFN) 3 million IU thrice weekly s.c. alone
Trial: 9862245
Drug: Ribavirin 600
RxNorm normalized name: ribavirin 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ribavirin 600 mg twice daily p.o. alone
Trial: 9862245
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (IFN + ribavirin)
Trial: 2146325
Drug: 13-cis retinoic
RxNorm normalized name: 13-cis-retinoic acid
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 13-cis retinoic acid (1 mg/kg/day for 4 months)
Trial: 7375893
Drug: Lillehei-Kaster (L-K)
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lillehei-Kaster (L-K) valve
Trial: 29727544
Drug: Fuyang Huayu
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fuyang Huayu Prescription (Traditional Chinese Medicine)
Trial: 29727544
Drug: Endocrine therapy
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endocrine therapy and chemotherapy (Control)
Trial: 31618812
Drug: Saffron (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saffron (20 mg)
Trial: 28181975
Drug: Auricular acupressure
RxNorm normalized name: fluocinolone
DrugBank: Fluocinolone (DB12553)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular acupressure therapy (2 weeks, 2 times per week, using auricular acupressure needle on skin paper tape)
Trial: 10320260
Drug: Lidocaine (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (standard antiarrhythmic dose)
Trial: 3312207
Drug: Cefamandole (five
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefamandole (five doses)
Trial: 3312207
Drug: Single preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single preoperative dose of cefamandole
Trial: 27432017
Drug: Hospital-to-community medication
RxNorm normalized name: zinc pyrithione Medicated Liquid Soap [Born To Be Mild]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital-to-community medication records scheme
Trial: 24094767
Drug: ALN-PCS (0.400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALN-PCS (0.400 mg/kg)
Trial: 17398083
Drug: 5%M+70%E/T‐gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5%M+70%E/T‐gel
Trial: 17398083
Drug: 5%M/T‐gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5%M/T‐gel
Trial: 17398083
Drug: 70%E/T‐gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 70%E/T‐gel
Trial: 17398083
Drug: T‐gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T‐gel
Trial: 11955535
Drug: Regimen A:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen A: zidovudine plus lamivudine starting at 36 weeks' gestation, followed by oral intrapartum dosing and by 7 days' postpartum dosing of mothers and infants.
Trial: 9848308
Drug: Control slides
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control slides incubated with preabsorbed antibody or mouse immunoglobulin G
Trial: 24740588
Drug: 750 ml
RxNorm normalized name: ALCOHOL 750 mL in 1 L TOPICAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 ml of fresh coffee brew
Trial: 24740588
Drug: 750 ml
RxNorm normalized name: ALCOHOL 750 mL in 1 L TOPICAL GEL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 ml of water
Trial: 15084240
Drug: Red clover-derived
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red clover-derived isoflavone supplement
Trial: 15298795
Drug: Diphenhydramine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diphenhydramine (25 mg)
Trial: 24760656
Drug: OLM/AML/HCTZ 40/5/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OLM/AML/HCTZ 40/5/25 mg
Trial: 26176708
Drug: OLM/AML/HCTZ 40/10/12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OLM/AML/HCTZ 40/10/12.5 mg
Trial: 26176708
Drug: OLM/AML/HCTZ 40/10/25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OLM/AML/HCTZ 40/10/25 mg
Trial: 18446025
Drug: Sugar-free gum
RxNorm normalized name: Diabetic Multivitamin Sugar-Free Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugar-free gum containing 54 mg CPP-ACP
Trial: 8958892
Drug: Salmeterol 50
RxNorm normalized name: FLUTICAS 100/SALMETEROL 50 INHL DISK 14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol 50 micrograms twice daily (n = 22)
Trial: 3004088
Drug: 0.20 mg
RxNorm normalized name: FENTANYL 10.20 mg in 1 [USP'U] TRANSDERMAL PATCH [Fentanyl]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.20 mg kg‐1 etomidate
Trial: 11701073
Drug: Isotonic sodium
RxNorm normalized name: ISOTONIC SODIUM CHLORIDE SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic sodium chloride solution (ISCS)
Trial: 17478034
Drug: Propionyl L‐carnitine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propionyl L‐carnitine (PLC) alone (2 g/d)
Trial: 17478034
Drug: Propionyl L‐carnitine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propionyl L‐carnitine (PLC) plus sildenafil (50 mg/d twice weekly)
Trial: 15620433
Drug: rosiglitazone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosiglitazone (4 mg per day for 12 weeks)
Trial: 10623334
Drug: Lower procaterol
RxNorm normalized name: procaterol
DrugBank: Procaterol (DB01366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower procaterol dose via large-volume spacer
Trial: 31789898
Drug: Ropivacaine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 10 mg in 2.5 ml saline (4 mg/ml)
Trial: 31789898
Drug: Ropivacaine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 10 mg in 5 ml saline (2 mg/ml)
Trial: 31789898
Drug: Ropivacaine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 10 mg in 10 ml saline (1 mg/ml)
Trial: 31789898
Drug: Ropivacaine 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 10 mg in 20 ml saline (0.5 mg/ml)
Trial: 25681448
Drug: Delayed-release dimethyl
RxNorm normalized name: dimethyl fumarate Delayed Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed-release dimethyl fumarate (DMF) 240 mg twice daily (BID)
Trial: 25681448
Drug: Subcutaneous glatiramer
RxNorm normalized name: Glatiramer
DrugBank: Glatiramer (DB05259)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous glatiramer acetate 20 mg once daily (active reference comparator)
Trial: 21277255
Drug: ramelteon 4
RxNorm normalized name: Ramelteon
DrugBank: Ramelteon (DB00980)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ramelteon 4 or 8 mg, titrated up to 16 mg if necessary for 24 weeks
Trial: 28885365
Drug: Neuromuscular electrical
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Neuromuscular electrical stimulation plus EMG-biofeedback therapy
Trial: 23266209
Drug: High-dose DHA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose DHA (100 mg/kg/day for the first month and 1g per day thereafter for 12 months)
Trial: 16680932
Drug: Fexofenadine hydrochloride
RxNorm normalized name: Fexofenadine Hydrochloride
DrugBank: Fexofenadine (DB00950)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fexofenadine hydrochloride (60 mg) pretreatment 2 hours before immunization injection
Trial: 8169755
Drug: High-dose RSV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose RSV immune globulin (750 mg/kg, 15 ml/kg)
Trial: 8169755
Drug: Low-dose RSV
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose RSV immune globulin (150 mg/kg, 3 ml/kg)
Trial: 8169755
Drug: High-dose RSV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose RSV immune globulin
Trial: 913294
Drug: Propranolol (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (160 mg/d)
Trial: 3275861
Drug: Placebo (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (500 mg lactose/d)
Trial: 3275861
Drug: Terbutaline (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (15 mg/d)
Trial: 24135845
Drug: Dextroamphetamine (AMP)
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine (AMP) 10 mg
Trial: 24135845
Drug: Dextroamphetamine (AMP)
DrugBank: Dextroamphetamine (DB01576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextroamphetamine (AMP) 20 mg
Trial: 23224510
Drug: Δ(9)-tetrahydrocannabinol (THC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Δ(9)-tetrahydrocannabinol (THC) 7.5 mg
Trial: 15157730
Drug: Placebo via
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo via metered-dose inhaler and Aerochamber, twice daily for 2 years
Trial: 8503339
Drug: Flutamide 750
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide 750 mg/day
Trial: 8503339
Drug: Flutamide 375
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide 375 mg/day (hormone-treated patients)
Trial: 3067610
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g of L-carnitine by intravenous infusion
Trial: 3067610
Drug: 0.5 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g/kg of ethanol in the form of white wine
Trial: 3067610
Drug: L-carnitine alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine alone
Trial: 26567593
Drug: Anaferon (ultra-high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anaferon (ultra-high dilutions of antibodies to human interferon γ), n=20
Trial: 16542795
Drug: 20 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 Gy radiation therapy (RT)
Trial: 16542795
Drug: 10 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 Gy radiation therapy (RT)
Trial: 16542795
Drug: No flank
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No flank radiation therapy (RT)
Trial: 12677011
Drug: Intra-arterial pro-urokinase
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial pro-urokinase (r-proUK) treatment
Trial: 2277578
Drug: 0.375% plain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.375% plain marcaine with 1:200000 epinephrine 10 mL to each side (Group C)
Trial: 8610862
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg metoclopramide
Trial: 25581426
Drug: Red clover
RxNorm normalized name: Red clover
DrugBank: Trifolium pratense pollen (DB15530)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red clover (40 mg dried leaves, 2 capsules daily for 12 weeks)
Trial: 25581426
Drug: Placebo (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (40 mg starch, 2 capsules daily for 12 weeks)